Kaybiotech

Delhi, India Founded: 2015 • Age: 11 yrs
Online platform selling medicines for various health conditions and treatments.
Annual revenue $3.0M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 7 Services tracked
Competitors - Brand Intelligence

About Kaybiotech

Kaybiotech is a company based in Delhi (India) founded in 2015. It operates as a B2C and D2C. Kaybiotech offers products and services including Glivec 400mg Tablet, Instgra Tablets 50mg, Sildenafil Citrate 100mg, Retino-A 0.1% Cream, and Forxiga 10mg Tablet.

  • Headquarter Delhi, India
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Kay Biotech Private Limited
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $2.96 M (USD)
    -3.03
    as on Mar 31, 2023
  • Net Profit
    $11.65 K (USD)
    86.94
    as on Mar 31, 2023
  • EBITDA
    $23.76 K (USD)
    139.5
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kaybiotech

Kaybiotech offers a comprehensive portfolio of products and services, including Glivec 400mg Tablet, Instgra Tablets 50mg, Sildenafil Citrate 100mg, Retino-A 0.1% Cream, and Forxiga 10mg Tablet.

Product name locked
Category locked
Primary

Tablet for cancer treatment and management

Product name locked
Category locked
Locked

Medication for HIV infection control

Product name locked
Category locked
Locked

Treatment for erectile dysfunction symptoms

Product name locked
Category locked
Locked

Cream for skin care and condition improvement

Product name locked
Category locked
Locked

Tablet for diabetes blood sugar regulation

Product name locked
Category locked
Locked

Antibiotic for infection-related treatments

Product name locked
Category locked
Locked

Medication for hepatitis virus management

Funding Insights of Kaybiotech

Premium access

Detailed funding history for Kaybiotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kaybiotech

Investments
Premium access

Investment portfolio details for Kaybiotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kaybiotech

Premium access

Detailed financials for Kaybiotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kaybiotech Comparisons

Kaybiotech Primary company
Description
Online platform selling medicines for various health conditi...
Location
Delhi, India
Founded Year
2015
Annual Revenue
$2.96 M (USD)
Net Profit
$11.65 K (USD)
EBITDA
$23.76 K (USD)
Employees
Not available
Premium access

Peer comparison for Kaybiotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kaybiotech

Premium access

Detailed competitors of Kaybiotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kaybiotech

Premium access

Complete news archive for Kaybiotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaybiotech

Kaybiotech was founded in 2015.

Kaybiotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Annual revenue of Kaybiotech is $2.96M as on Mar 31, 2023.

Kay Biotech operates as an online pharmacy based in Delhi, India, offering a diverse range of pharmaceutical products including anti-cancer drugs, HIV treatments, and diabetes medications. They facilitate direct purchases through their website with discounted prices, secure payments, and global delivery options. The company serves individual customers by categorizing products for easy access and ensuring affordability through various deals.

Kaybiotech offers Glivec 400mg Tablet, Instgra Tablets 50mg, Sildenafil Citrate 100mg, Retino-A 0.1% Cream, and 3 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available